Text Size

Rituximab+Standard CHOP vs Rituximab+bi-Weekly CHOP for Untreated Stage III/IV Low-Grade B-Cell Lymphoma (JCOG0203)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Japan Clinical Oncology Group.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Ministry of Health, Labour and Welfare, Japan
Information provided by:
Japan Clinical Oncology Group
ClinicalTrials.gov Identifier:
NCT00147121
First received: September 5, 2005
Last updated: February 2, 2009
Last verified: February 2009
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2010
  Estimated Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
No publications provided by Japan Clinical Oncology Group

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):